Iopromide 623.4mg (equivalent to 300mg of iodine) per mL; soln; preservative-free; contains tromethamine and edetate calcium disodium. Intra-arterial (Cerebral arteriography): Carotid arteries: 3–12mL ...

Iopromide 768.86mg (equivalent to 370mg of iodine) per mL; soln; preservative-free; contains tromethamine and edetate calcium disodium. Intra-arterial (Coronary arteriography and left ventriculography ...

Schering AG (Berlin, Germany) voluntarily issued a worldwide recall of all lots of its X-ray contrast agent "Ultravist Injection" 370 mgI/mL (iopromide injection) because particulate matter and ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

"The approval of Ultravist-300 and -370 in contrast-enhanced mammography gives physicians a new imaging option where conventional mammography might not be enough," said Konstanze Diefenbach, head of ...

Ultravist™-300, -370 is now the only contrast agent in the U.S. indicated to visualize known or suspected lesions of the breast in adults, as an adjunct to mammography and/or ultrasound ...

Bayer announced that its iodine-based contrast agent Ultravist-300, -370 is now approved for contrast-enhanced mammography (CEM) in the EU. The product can be used to evaluate and detect lesions of ...

Schering AG yesterday pulled its X-ray contrast agent Ultravist (iopromide injection) from most global markets after a potential safety issue was uncovered and delivered poor Phase III data for its ...

Breast cancer remains one of the most prevalent cancers worldwide, accounting for 11.7 per cent of all cancer cases. In India, it is a leading cause of cancer-related deaths among […] ...